These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34881415)

  • 1. High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia.
    Almudarra S; Kamel S; Saleh E; Alaswad R; Alruwaily A; Almowald S; Alqunaibet AM; Almudiaheem A; Almutlaq H; Alserehi H; Almalki S; Bahlaq MA; Alsahafi AJ; Alsaif F; Khojah AT; Al-Tawfiq JA; Asiri SI; Assiri A; Jokhdar H
    Infection; 2022 Jun; 50(3):643-649. PubMed ID: 34881415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia.
    Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S
    Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia.
    Mahallawi WH; Alsarani MA; Aljohani RH; Alluhaibi AA; Alamri TH; Ibrahim NA; Mahallawi KH; Khabourd OF
    Ann Saudi Med; 2022; 42(2):69-74. PubMed ID: 35380058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
    Alserehi HA; Alqunaibet AM; Al-Tawfiq JA; Alharbi NK; Alshukairi AN; Alanazi KH; Bin Saleh GM; Alshehri AM; Almasoud A; Hashem AM; Alruwaily AR; Alaswad RH; Al-Mutlaq HM; Almudaiheem AA; Othman FM; Aldakeel SA; Abu Ghararah MR; Jokhdar HA; Algwizani AR; Almudarra SS; Albarrag AM
    Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115273. PubMed ID: 33296851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia.
    Alhazmi A; Alamer E; Abdelwahab S; Khamjan N; Hamami A; Haddad M; Darraj M; Hashem AM; Algaissi A
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia.
    Alosaimi MF; Alhetheel A; Aleisa KA; Altwerki AA; Alenezy NM; Almutairi EM; Alothaim LO; Khalid AMA; Alayed KM; Almazyad MA; BinMoammar TA; Alshobaili FA; Al-Shahrani FS; Alsubaie S; Hasanato RM
    Saudi Med J; 2021 Aug; 42(8):853-861. PubMed ID: 34344809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia.
    Alharbi NK; Alghnam S; Algaissi A; Albalawi H; Alenazi MW; Albargawi AM; Alharbi AG; Alhazmi A; Al Qarni A; Alfarhan A; Zowawi HM; Alhatmi H; Alghamdi J; Alroqi F; Batarfi K; Arabi YM; Hashem AM; Bosaeed M; Aldibasi O
    J Infect Public Health; 2021 Jul; 14(7):832-838. PubMed ID: 34118732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
    PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 antibody prevalence among healthcare workers: A cross-sectional study at a quaternary healthcare center in Saudi Arabia.
    Amer HA; Abdallah HA; Alkheledan HS; Alzarzour SH; Shrahily A; Tamim H; Alqahtani SA; Memish ZA
    J Infect Public Health; 2022 Mar; 15(3):343-348. PubMed ID: 35167996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
    Alhabbab RY; Alsaieedi A; Algaissi A; Almahboub S; Al-Raddadi RM; Shabouni OI; Alhabbab R; Alfaraj AA; Alamri SS; Aljehani ND; Abdulal RH; Alfaleh MA; Abujamel TS; Alkayyal AA; Mahmoud AB; Abuzenadah AM; Hashem AM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.
    Müller MA; Meyer B; Corman VM; Al-Masri M; Turkestani A; Ritz D; Sieberg A; Aldabbagh S; Bosch BJ; Lattwein E; Alhakeem RF; Assiri AM; Albarrak AM; Al-Shangiti AM; Al-Tawfiq JA; Wikramaratna P; Alrabeeah AA; Drosten C; Memish ZA
    Lancet Infect Dis; 2015 May; 15(5):559-64. PubMed ID: 25863564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of SARS-CoV-2 Anti-Spike IgG Antibody in Women and Children in Madinah, Saudi Arabia: A Single-Center Study.
    Mahallawi WH; Ibrahim NA; Aljohani AS; Shaikh EA; Nafe RH; Khan AM; Mumena WA
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
    Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.
    Irenge LM; Bulakali HM; Akonkwa AI; Ambroise J; Gala JL
    Epidemiol Infect; 2023 Feb; 151():e24. PubMed ID: 36775822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
    Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
    Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
    BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.
    Kahlert CR; Persi R; Güsewell S; Egger T; Leal-Neto OB; Sumer J; Flury D; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Stocker R; Vuichard-Gysin D; Wiggli B; Albrich WC; Babouee Flury B; Besold U; Fehr J; Kuster SP; McGeer A; Risch L; Schlegel M; Friedl A; Vernazza P; Kohler P
    Clin Microbiol Infect; 2021 Sep; 27(9):1336-1344. PubMed ID: 34020033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.